Hemoglobin in Medical Technology
Navigation Links
Hemoglobin in Medical Technology
... including: noninvasive and continuous total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), ... SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), ... and deliver clinical improvement over alternative hemoglobin and fluid assessment measurement capabilities to ...
... of using intermittent, invasive measurements of hemoglobin to help guide transfusion decisions may ... not simply be based on any particular level of hemoglobin but rather a thorough evaluation of the patient, including whether hemoglobin levels are stable or changing. The ability to ...
... sufficient to sustain therapeutic elevation of hemoglobin in most patients. The earliest patients to receive treatment have shown sustained hemoglobin within the target range for four months without ... comparable low dose does not result in sufficient hemoglobin levels in most patients. By having ...
... blood vessels. In sickle cell disease, the hemoglobin carried by the red blood cells is abnormal, ... event. Daytime Steady-State hemoglobin Saturation Is a Determinant of Cerebral Artery ... , TX This study determined that low hemoglobin saturation (a decrease in the amount of oxygen in ...
... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ... administered ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ... ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... trials of patients with cancer. A rate of hemoglobin rise of 1 g/dL over 2 weeks may contribute ...
... (Hp), a common serum protein, is to bind free hemoglobin released from red blood cells. Extracellular hemoglobin (hemoglobin not found in red blood cells) is ... damage. Haptoglobin binds to this extracellular hemoglobin and inhibits hemoglobin induced oxidation. ...
... improvement in fatigue, (ES: +1.0) when the hemoglobin level increased as compared to anemic cancer ... improvement in fatigue (ES:+0.72) when hemoglobin levels did not improve compared to ... did not change meaningfully (ES:+0.15) when hemoglobin levels did not improve. * Importantly, ...
... in cancer chemotherapy patients with various hemoglobin (Hb) levels prior to or during administration ... that when patients achieved lower mean hemoglobin levels during ESA therapy for ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
... associations between lower mean baseline hemoglobin (Hb) levels and the rate of blood transfusions, ... Chemotherapy Patients Based on Achieved hemoglobin (Hb) Levels Kay Larholt, Sc.D., Abt Associates, ... chemotherapy-treated oncology patients who had hemoglobin concentrations less than 10 g/dL prior to ...
... hypertension or diabetes, and show the impact on hemoglobin (Hb) control using a software-based management ... both on study outcomes. Data on the Impact on hemoglobin Control Using a Software-Based Management Tool -- Abstract: Use of Epoetin Alfa in Maintaining hemoglobin Control Through a Software-Based Management ...
... patients seen in some studies with high hemoglobin targets; -- Recommend additional research to ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ...
... Noninvasive hemoglobin Receives Rave Reviews from Attendees at Masimo's ... the world were able to preview noninvasive total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM)) as part ... Continuous Noninvasive Measurement of hemoglobin via Pulse CO-Oximetry(1), a clinical study led by ...
... ESA treatment. In addition, wide variability in hemoglobin levels prior to transfusion was reported. These ... analyses indicate that the presence of a lower hemoglobin when ESA therapy was initiated was associated ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
... anemic as a result of chemotherapy when their hemoglobin approaches or falls below 10 g/dL, as well as ... -- Suggests that when using ESAs, hemoglobin can be raised to (or near) a concentration of ... Dose reductions are also recommended when hemoglobin rise exceeds 1 g/dL in any two-week period or ...
... the medical community to achieve a consensus on hemoglobin and dosing levels for ... Without ESA therapy, ESRD patients may develop hemoglobin levels that are dangerously low. Before ESAs were ... and non- dialysis CKD patients should target hemoglobin levels in the range of 11 to 12 g/dL. These ...
... by the FDA Advisory Committees evaluated hemoglobin targets above 13 grams per deciliter of blood ... for all ESAs was revised to reflect a maximum hemoglobin of 12 g/dL. When patients are treated according ... experience the greatest benefit from a hemoglobin of between 10-12 g/dL, and that patients who ...
... the PROCRIT and placebo groups. However, the hemoglobin increase was greater in the PROCRIT group. ... to an ICU for two days or more with a hemoglobin (Hb) less than 12 grams per deciliter of blood ... of PROCRIT that will gradually increase the hemoglobin (Hb) concentration to the lowest level sufficient ...
... and continuously measures SpCO and SpMet, in addition to total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), PVI, oxyhemoglobin (SpO2), pulse ... Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), ...
... (head) hemorrhage or overt sign of bleeding associated with a decrease in hemoglobin concentration of greater than 50 g/L (or hematocrit greater than 15 ... meet the requirements for TIMI major bleed, associated with a decrease in hemoglobin concentration of 30g/L to less than or equal to 50 g/L (or hematocrit 9-15 ...
... in anemia with Soliris treatment was also indicated by increased hemoglobin levels. hemoglobin levels increased from a median of 7.6 g/dL (7.9 +/- 0.3) at ...
... once daily demonstrated statistically significant reductions in hemoglobin A1c (HbA1c) versus placebo as a monotherapy and as an add-on therapy with ... 13 years. Mean age, in all studies, was between 53 and 57 years. About hemoglobin A1c (HbA1c) HbA1c is a measure of an individual's average blood sugar ...
... subjects demonstrated an excellent favorable downward trend in their hemoglobin A1C levels. These results suggest that when administered to people with ... to cardiovascular causes such as heart attack and stroke," said Evans. hemoglobin A1C is an indicator of average blood glucose control over two to three ...
... studies, levels of C-reactive protein (CRP), a marker of inflammation, and hemoglobin levels, showed an improvement within two weeks and remained at normal ... In addition, the systemic symptoms of RA include fatigue, decreased hemoglobin and osteoporosis and may contribute to shortening life expectancy by ...
... - MAXIMA findings in The Lancet affirm the maintenance of hemoglobin levels with less frequent dosing - NUTLEY, N.J., ... disease (CKD) patients with dosing once every two weeks and maintained hemoglobin levels in CKD patients with dosing intervals up to once monthly. In the ...
... the primary endpoint was reached with patients benefiting from a clinically important and statistically significant (p<0.0001) increase in mean hemoglobin concentration compared with baseline after receiving velaglucerase alfa at 60 U/kg IV every other week for 12 months. Statistically significant ...
... of using intermittent, invasive measurements of hemoglobin to help guide transfusion decisions may ... not simply be based on any particular level of hemoglobin but rather a thorough evaluation of the patient, including whether hemoglobin levels are stable or changing. The ability to ...
... sufficient to sustain therapeutic elevation of hemoglobin in most patients. The earliest patients to receive treatment have shown sustained hemoglobin within the target range for four months without ... comparable low dose does not result in sufficient hemoglobin levels in most patients. By having ...
... blood vessels. In sickle cell disease, the hemoglobin carried by the red blood cells is abnormal, ... event. Daytime Steady-State hemoglobin Saturation Is a Determinant of Cerebral Artery ... , TX This study determined that low hemoglobin saturation (a decrease in the amount of oxygen in ...
... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ... administered ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
... in the blood of an immature fetal form of hemoglobin in red blood cells. This immature hemoglobin, ... hydroxyurea encourages the formation of fetal hemoglobin and alleviates disease symptoms. "While ... use gene transfer to permanently increase fetal hemoglobin levels," said Derek Persons, M.D., Ph.D., ...... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ... ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... trials of patients with cancer. A rate of hemoglobin rise of 1 g/dL over 2 weeks may contribute ...
... (Hp), a common serum protein, is to bind free hemoglobin released from red blood cells. Extracellular hemoglobin (hemoglobin not found in red blood cells) is ... damage. Haptoglobin binds to this extracellular hemoglobin and inhibits hemoglobin induced oxidation. ...
... improvement in fatigue, (ES: +1.0) when the hemoglobin level increased as compared to anemic cancer ... improvement in fatigue (ES:+0.72) when hemoglobin levels did not improve compared to ... did not change meaningfully (ES:+0.15) when hemoglobin levels did not improve. * Importantly, ...
DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
... GlycoMark May Be a More Effective Monitor Than hemoglobin A1C of Exenatide, Sitagliptin, Pramlintide and ... after-meal glucose levels, than the gold standard hemoglobin A1C test in moderately controlled patients with ... test (GlycoMark) correlated more strongly than hemoglobin A1C with all self-monitored plasma glucose (SMPG) ...... in cancer chemotherapy patients with various hemoglobin (Hb) levels prior to or during administration ... that when patients achieved lower mean hemoglobin levels during ESA therapy for ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
... associations between lower mean baseline hemoglobin (Hb) levels and the rate of blood transfusions, ... Chemotherapy Patients Based on Achieved hemoglobin (Hb) Levels Kay Larholt, Sc.D., Abt Associates, ... chemotherapy-treated oncology patients who had hemoglobin concentrations less than 10 g/dL prior to ...
... hypertension or diabetes, and show the impact on hemoglobin (Hb) control using a software-based management ... both on study outcomes. Data on the Impact on hemoglobin Control Using a Software-Based Management Tool -- Abstract: Use of Epoetin Alfa in Maintaining hemoglobin Control Through a Software-Based Management ...
Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ... and cervical cancers when dosed to target a hemoglobin of greater than or equal to 12 g/dL. -- The ...... patients seen in some studies with high hemoglobin targets; -- Recommend additional research to ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ... Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL. ...
... Noninvasive hemoglobin Receives Rave Reviews from Attendees at Masimo's ... the world were able to preview noninvasive total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM)) as part ... Continuous Noninvasive Measurement of hemoglobin via Pulse CO-Oximetry(1), a clinical study led by ...
... ESA treatment. In addition, wide variability in hemoglobin levels prior to transfusion was reported. These ... analyses indicate that the presence of a lower hemoglobin when ESA therapy was initiated was associated ... agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in ...
Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood
... differences are significant. The level of hemoglobin (the oxygen-carrying molecule in the blood) ... math, and executive function. Patients with lower hemoglobin scores had lower IQ scores, and ischemic lesions ... of the neuropsychological impairment observed. hemoglobin levels, age, and hippocampal volume were ...PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
... greater than or equal to 9 weeks and baseline hemoglobin greater than or equal to 11 and less than or ... intervention with Epoetin alfa when hemoglobin decreased to <11 g/dL. -- Abstract: Erythroid ... with non-myeloid malignancy, baseline hemoglobin greater than or equal to 11 and less than or ...Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
... with the use of ESAs "when dosed to target a hemoglobin of >= 12 g/dL" and instructs physicians to "use ... to establish the risk of using ESAs when hemoglobin levels are less than 12 g/dL. The CMS NCD, on the ... to suggest that initiating ESA treatment at a hemoglobin level >10 g/dL significantly reduces the risk of ...Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
... (CMS), which denies coverage for ESAs above the hemoglobin levels of 10 gm/dL. US Oncology and its ... NCD policy, Medicare beneficiaries risk reaching hemoglobin levels oncologists regard as inappropriately low ... not been excluded when ESAs are dosed to target a hemoglobin of < 12 gm/dL." While US Oncology agrees with ...... anemic as a result of chemotherapy when their hemoglobin approaches or falls below 10 g/dL, as well as ... -- Suggests that when using ESAs, hemoglobin can be raised to (or near) a concentration of ... Dose reductions are also recommended when hemoglobin rise exceeds 1 g/dL in any two-week period or ...
New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
... intravenous (IV) C.E.R.A. maintains stable hemoglobin (Hb) in dialysis patients (pts), irrespective ... Exhibit Hall, Moscone Center) -- Stable hemoglobin (Hb) levels are maintained with once-monthly ... -- Once-monthly C.E.R.A. maintains stable hemoglobin (Hb) in patients (pts) with chronic kidney ...... the medical community to achieve a consensus on hemoglobin and dosing levels for ... Without ESA therapy, ESRD patients may develop hemoglobin levels that are dangerously low. Before ESAs were ... and non- dialysis CKD patients should target hemoglobin levels in the range of 11 to 12 g/dL. These ...
... by the FDA Advisory Committees evaluated hemoglobin targets above 13 grams per deciliter of blood ... for all ESAs was revised to reflect a maximum hemoglobin of 12 g/dL. When patients are treated according ... experience the greatest benefit from a hemoglobin of between 10-12 g/dL, and that patients who ...
... the PROCRIT and placebo groups. However, the hemoglobin increase was greater in the PROCRIT group. ... to an ICU for two days or more with a hemoglobin (Hb) less than 12 grams per deciliter of blood ... of PROCRIT that will gradually increase the hemoglobin (Hb) concentration to the lowest level sufficient ...
... and continuously measures SpCO and SpMet, in addition to total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), PVI, oxyhemoglobin (SpO2), pulse ... Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), ...
... (head) hemorrhage or overt sign of bleeding associated with a decrease in hemoglobin concentration of greater than 50 g/L (or hematocrit greater than 15 ... meet the requirements for TIMI major bleed, associated with a decrease in hemoglobin concentration of 30g/L to less than or equal to 50 g/L (or hematocrit 9-15 ...
... in anemia with Soliris treatment was also indicated by increased hemoglobin levels. hemoglobin levels increased from a median of 7.6 g/dL (7.9 +/- 0.3) at ...
Stroke Study Reveals a Key Target For Improving Treatment
... The level of bleeding in the brain was measured by assessing the amount of hemoglobin in the stroke-affected side of the brain. Mice that had received imatinib before tPA had 50 percent less hemoglobin than those that had not received pretreatment. This last experiment is ...... once daily demonstrated statistically significant reductions in hemoglobin A1c (HbA1c) versus placebo as a monotherapy and as an add-on therapy with ... 13 years. Mean age, in all studies, was between 53 and 57 years. About hemoglobin A1c (HbA1c) HbA1c is a measure of an individual's average blood sugar ...
Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
... we are seeking for PolyHeme(R), the treatment of life-threatening hemoglobin levels when blood transfusion is required and red blood cells are not ... red blood cell substitute. It is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood ...... subjects demonstrated an excellent favorable downward trend in their hemoglobin A1C levels. These results suggest that when administered to people with ... to cardiovascular causes such as heart attack and stroke," said Evans. hemoglobin A1C is an indicator of average blood glucose control over two to three ...
Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
... a phase III study. The primary efficacy endpoint was the change in blood hemoglobin level from baseline to end of study, and secondary endpoints included ... achieved similar results. In the low-dose group, the increase in hemoglobin compared to placebo was not statistically significant. Treatment with ...Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
... RCC diagnosis to randomization, Karnofsky performance status of 60 or 70, hemoglobin less than the lower limit of normal, corrected calcium of greater than 10 ... common grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), glucose increased (16%), ...... studies, levels of C-reactive protein (CRP), a marker of inflammation, and hemoglobin levels, showed an improvement within two weeks and remained at normal ... In addition, the systemic symptoms of RA include fatigue, decreased hemoglobin and osteoporosis and may contribute to shortening life expectancy by ...
... - MAXIMA findings in The Lancet affirm the maintenance of hemoglobin levels with less frequent dosing - NUTLEY, N.J., ... disease (CKD) patients with dosing once every two weeks and maintained hemoglobin levels in CKD patients with dosing intervals up to once monthly. In the ...
Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
... concentration of SFP that will maintain iron balance within the target hemoglobin range, in patients undergoing hemodialysis. Secondary endpoints include evaluating efficacy for changes in hemoglobin levels over time, reticulocyte hemoglobin content, incidence of systemic ...... the primary endpoint was reached with patients benefiting from a clinically important and statistically significant (p<0.0001) increase in mean hemoglobin concentration compared with baseline after receiving velaglucerase alfa at 60 U/kg IV every other week for 12 months. Statistically significant ...
Spherix Announces Positive Phase 2 Study Results
... three separate low doses, proved to be effective for at least 6 months in reducing HbA1c, a key indicator of Type 2 diabetes that monitors glycated hemoglobin in the blood. These data, combined with the fact that Naturlose is a naturally occurring compound with no known contraindications to current Type 2 ...Other ContentsmonosaccharidesmonotremesmorphologymorphologymorphologymorphologymorphologymossmosaicismmotifmotifmotifmotifOther TagsconductiveTrocarsXcelXcelXcelXcelSHEARSSayeOther Tagsbenchmark 2researched 2researched 3continual 2turned 2turned 3turned 4turned 5turned 6turned 7turned 8turned 9turned 10informed 2informed 3prestigious 2
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 1DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 2Exposure to Holocaust May Have Raised Cancer Risks 60111 1Exposure to Holocaust May Have Raised Cancer Risks 60111 2Heart Disease Gender Gap Narrows 60108 1Heart Disease Gender Gap Narrows 60108 2Heart Disease Gender Gap Narrows 60108 3(Date:12/5/2009)..., , SATURDAY, Dec. 5 (HealthDay News) -- T... asthma can have bad reactions to certain holiday ...nt sneezing and wheezing, according to the America...). , Those who are allergic to live evergreens may...th live and artificial trees can trigger symptoms,...
(Date:12/5/2009)...the launch of International Solutions, an innovati...n which follows the acclaimed modular design of it... the flexibility to add or remove a wide range of ...onal Solutions enables customers to tailor their b...ir country of residence. , ...
(Date:12/4/2009)...Medical Systems (NYSE: VAR ) announced today tha...Annual Meeting of Stockholders for February 11, 20...eting will be held at the Crowne Plaza Cabana Hote...:30 p.m. PT. ,, The meeting will be webcast by Tho...al Systems, website at http://www.varian.com/inve...
(Date:12/4/2009)... won the Patient,s Choice Award as the favorite di...ted by the online website, www.weedmaps.com. Des...mmunity has selected Medithrive as the preeminent ...he rapid rise and popularity of Medithrive confirm...nsumer, provides a beautiful environment with frie...
(Date:12/4/2009)...t of America, Inc. ("HTA"), a self-managed, non-tr...execution of a purchase and sale agreement to acqu...ted in San Angelo, Texas, Corsicana, Texas, and Fo...The closing of the acquisition is subject to the s...oximately 92,500 square foot portfolio is 100% lea...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2[0] Keep Asthma, Allergies at Bay for the Holidays[0] AVIVA's Private Health Insurance Products Solutions Go International[0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] Medithrive Voted #1 Medicinal Marijuana Dispensary in Bay Area[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |